Axios International

Since 1997, we've worked to transform access to healthcare by putting quality care and treatment within reach so all people can achieve better health.

[Axios International @Axiosint]

At the "Priorities and Challenges in Polish and European Drug Policy" conference organized by Termedia, our CEO Joseph Saba shares his perspective on how "me first" trade policies could unravel decades of progress on medicine access.
Watch: https://t.co/NaEWmU3ZlH

#MarketAccess

[Axios International @Axiosint]

More accurate affordability assessments lead to more sustainable access programs and better outcomes for patients. That’s the PFET difference.

Learn more about Axios' means-based assessment tool: https://t.co/XQO3F7j04P

#WeFindaWay #MarketAccess #AccessToMedicines

[Axios International @Axiosint]

A new Axios study analyzing data from 18,500+ cancer patients across 20 countries shows how access program data can help predict survival and treatment adherence. Predictive access solutions are the next frontier of healthcare access.

Read more: https://t.co/gA9Z1vkjwY

[Axios International @Axiosint]

Healthcare access doesn't happen on its own. It takes people who can solve problems, build systems, support patients, and keep programs running smoothly. We're growing our team and hiring for several exciting opportunities across our global organization: https://t.co/8he0yJgdhT

[Axios International @Axiosint]

We're proud to share that we've received an excellent result in our recent Information Security and Data Privacy Assessment conducted by CyberVadis. Protecting information entrusted to us is a responsibility we take seriously and critical to delivering access to treatment.

[Axios International @Axiosint]

Today is #WorldMSDay. For 14 years across four countries in the Middle East, we've supported more than 1,000 people living with MS—helping them access treatment and stay on therapy. Today, we recognize the strength of patients, families, and caregivers navigating MS every day. 🧡

[Axios International @Axiosint]

Earlier this month, Majdoline Mughari, Regional Operations Lead, attended #SIPHA26, the Saudi International Pharmaceutical Conference hosted by the Saudi Pharmaceutical Society. It was a valuable opportunity to exchange perspectives with partners shaping access across the region.

[Axios International @Axiosint]

At #ISPORAnnual, much of the discussion focused on MFN pricing and its global implications. Our conversations on patient-level affordability in self-pay and LMIC markets offered a different perspective: access models must evolve to reflect patient reality.

[Axios International @Axiosint]

Two patients may share the same diagnosis, but different financial realities. Axios’ Patient Financial Eligibility Tool helps determine what patients can realistically contribute toward treatment for more sustainable access solutions and better outcomes. https://t.co/7vNineP80v

[Axios International @Axiosint]

Sustainable access in countries with large self-pay populations requires more than country-level insights. It requires understanding what patients can actually afford.

If this challenge resonates with you, join us at #ISPOR2026 in Philadelphia next week.

[Axios International @Axiosint]

Meet our India-based team supporting access programs across the country. Working across four regions and speaking seven languages, this dedicated team helps patients navigate every step of their treatment journey.

Learn more: https://t.co/oIkfNZILDa or [email protected].

[Axios International @Axiosint]

Sustainable access strategies aren’t built on assumptions. Axios uses proprietary affordability and willingness tools to turn real-world insights into practical, patient-centered strategies that help patients access and complete treatment. Learn more: https://t.co/T6mGCkVoxP

[Axios International @Axiosint]

Great to be at the 2nd Emirates Thoracic Congress last week. Spent time with our partners at the Emirates Cancer Society discussing how we can continue to work together to improve access to care and treatment for #cancer patients in the UAE. #WeFindAWay

[Axios International @Axiosint]

Our access programs share one goal: helping patients complete their full treatment, not just a few boxes. We design for continuity so patients don’t drop off early and miss out on full benefit. That's something to smile about. Learn more: https://t.co/8Bmq2t11bx

[Axios International @Axiosint]

Rana’s journey at Axios has been more than a career. It’s been a perspective shift. One of the most powerful lessons she’s learned? The true value of time. While it can pass unnoticed for many, for the patients we serve, every second matters.

#WeFindAWay #AccesstoHealthcare

[Axios International @Axiosint]

Today is #WorldHealthDay—a reminder that health belongs to everyone, everywhere. At Axios, #WeFindAWay means making #PatientAccess possible, regardless of the medicine, country, or challenge.Learn how: https://t.co/8Bmq2t11bx

#StandWithScience

[Axios International @Axiosint]

A patient with a heart condition. A child with a rare immune disorder. Someone navigating a cancer diagnosis far from home. Over the last decade, Axios has enabled access to 225 medications across 11 therapeutic areas. Whatever the medicine. Whoever the patient. #WeFindAWay.

[Axios International @Axiosint]

She didn’t say no. She just wasn’t ready. So Nageswari didn’t push. She listened and gave space. Until one day, the patient was ready. Because access isn’t just about affordability. It’s about feeling seen and supported.

At Axios, #WeFindAWay through compassion.

[Axios International @Axiosint]

Adherence isn’t just about taking a pill. It’s about creating the right support so patients can stay on treatment throughout their journey. Because every patient is different, our solutions are designed to meet real challenges with personalized support: https://t.co/XQ0VKnAu9W

[Axios International @Axiosint]

Our team recently attended the Regional Oncology Conference organized by the Kuwait Society for Smoking and Cancer Prevention + the Gulf Federation for Cancer Control to discuss improving access to oncology treatment.

More: https://t.co/UGmxf009Ph